Sickle-cell disease other imaging findings: Difference between revisions
Jump to navigation
Jump to search
(Template) |
Shyam Patel (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Sickle-cell disease}} | {{Sickle-cell disease}} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} {{shyam}} | ||
==Overview== | ==Overview== | ||
There is no significant role of other imaging modalities. However, a dual-energy X-ray absorptiometry (DEXA) scan can be done to assess for osteoporosis, since patients with sickle cell disease can have low bone density. | |||
==Other imaging findings== | ==Other imaging findings== | ||
A dual-energy X-ray absorptiometry (DEXA) scan can evaluate for bone loss.<ref name="pmid22924029">{{cite journal| author=Ballas SK, Kesen MR, Goldberg MF, Lutty GA, Dampier C, Osunkwo I et al.| title=Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. | journal=ScientificWorldJournal | year= 2012 | volume= 2012 | issue= | pages= 949535 | pmid=22924029 | doi=10.1100/2012/949535 | pmc=3415156 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22924029 }} </ref> | |||
==References== | ==References== | ||
Revision as of 04:41, 6 September 2016
|
Sickle-cell disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sickle-cell disease other imaging findings On the Web |
|
American Roentgen Ray Society Images of Sickle-cell disease other imaging findings |
|
Risk calculators and risk factors for Sickle-cell disease other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shyam Patel [2]
Overview
There is no significant role of other imaging modalities. However, a dual-energy X-ray absorptiometry (DEXA) scan can be done to assess for osteoporosis, since patients with sickle cell disease can have low bone density.
Other imaging findings
A dual-energy X-ray absorptiometry (DEXA) scan can evaluate for bone loss.[1]
References
- ↑ Ballas SK, Kesen MR, Goldberg MF, Lutty GA, Dampier C, Osunkwo I; et al. (2012). "Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management". ScientificWorldJournal. 2012: 949535. doi:10.1100/2012/949535. PMC 3415156. PMID 22924029.